Stay updated on Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page.

Latest updates to the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0; no study content or user-facing information was changed.SummaryDifference0.0%

- Check16 days agoChange DetectedThe page revision was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedA new Revision: v3.4.2 is shown, and an outdated government funding operating-status notice has been removed.SummaryDifference0.4%

- Check51 days agoChange DetectedAdded a banner notice about a lapse in government funding and the NIH Clinical Center's status with links for updates. The page revision label was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check58 days agoChange DetectedThe page adds a glossary toggle, a 'Last Update Submitted that Met QC Criteria' indicator, 'No FEAR Act Data' and 'Revision: v3.4.0', while removing the older 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' elements.SummaryDifference0.2%

- Check72 days agoChange DetectedMinor revision history updates show Revision: v3.3.4 added and Revision: v3.3.3 removed, which do not affect core content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page.